ATH 12.5% 0.4¢ alterity therapeutics limited

SRPT Duchenne Drug trial hits 5 year mark, page-52

  1. 4,443 Posts.
    lightbulb Created with Sketch. 1829
    Prana needs to manage all stakeholders effectively here. That includes the FDA as the proxy buyer for the entire USA market and with us stakeholders. FDA is the customer's representative here, like it or not. You have to engage. We complain about antagonists on this forum but Prana effectively gives them a free kick by being utterly mute on its activities, if they are doing anything at all.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
-0.001(12.5%)
Mkt cap ! $21.28M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $7.902K 2.037M

Buyers (Bids)

No. Vol. Price($)
41 53613756 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 127138639 21
View Market Depth
Last trade - 14.03pm 15/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.